Upadacitinib for anti-TNFα refractory immune checkpoint inhibitor–induced colitis: a case report
Although immune checkpoint inhibitors have revolutionized oncologic therapy, they are frequently associated with a wide spectrum of immune-related adverse events, most notably immune-mediated colitis (ImC). For cases of moderate-to-severe colitis, treatment typically involves corticosteroids with es...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publishing
2026-06-01
|
| Seri Bilgileri: | Therapeutic Advances in Gastroenterology |
| Online Erişim: | https://doi.org/10.1177/17562848261458694 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|